The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care

Clinical guidelines, CG137 - Issued: January 2012
This clinical guideline updates and replaces NICE clinical guideline 20 (published in 2004). It also updates and replaces NICE technology appraisal 76 (published in 2004) and NICE technology appraisal 79 (published in 2004).
It offers evidence-based advice on the care and treatment of children, young people and adults with epilepsy. New recommendations have been added for the pharmacological treatment of people with epilepsy, including the use of ketogenic diet.
November 2013: A footnote has been added to the NICE guideline (recommendation 1.9.1.4) and full guideline (recommendation 81) highlighting new advice issued by the MHRA about oral anti-epileptic drugs (AEDs) and switching between different manufacturers’ products of a particular drug. See the MHRA advice for more information. Also see the Medicines Evidence Commentary, which helps to contextualise the changes to the guideline.

• Other information

  • CG137 Epilepsy: guidance (web format)

  NICE Pathways

  This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
  Visit the NICE Pathway: epilepsy
  

  How this guidance was produced

  Background information

  • CG137 Epilepsy: press release

This page was last updated: 28 April 2014